These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 26546027)
1. Pembrolizumab: a new Drug That Can Induce Exacerbations of Psoriasis. Sahuquillo-Torralba A; Ballester-Sánchez R; Pujol-Marco C; Botella-Estrada R Actas Dermosifiliogr; 2016 Apr; 107(3):264-6. PubMed ID: 26546027 [No Abstract] [Full Text] [Related]
2. Rupioid psoriasis induced by pembrolizumab. Marti-Marti I; Gómez S; Riera-Monroig J; Carrera C; Mascaró JM Indian J Dermatol Venereol Leprol; 2020; 86(5):580-582. PubMed ID: 32719194 [No Abstract] [Full Text] [Related]
3. New Yellow Plaques in a Patient Taking Pembrolizumab. Massey PR; Jones KM; Fox MC JAMA Oncol; 2017 Jan; 3(1):119-120. PubMed ID: 27892986 [No Abstract] [Full Text] [Related]
4. Follicular psoriasis induced by pembrolizumab in a patient with advanced non-small-cell lung cancer. Scarfì F; Lacava R; Patrizi A; Tartari F; Ravaioli GM; Veronesi G; Lambertini M; Dika E Int J Dermatol; 2019 Aug; 58(8):e151-e152. PubMed ID: 30964199 [No Abstract] [Full Text] [Related]
5. Psoriasis caused by pembrolizumab treatment in advanced melanoma: A positive prognostic side effect? D'Erme AM; Fidanzi C; Janowska A; Allegrini G; Barbara C; Cupini S; Viacava P; Bagnoni G Dermatol Ther; 2021 Sep; 34(5):e15050. PubMed ID: 34212457 [No Abstract] [Full Text] [Related]